These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12827278)

  • 1. The mutator phenotype theory of carcinogenesis and the complex histopathology of tumours: support for the theory from the independent occurrence of nuclear abnormality, loss of specialisation and invasiveness among occasional neoplastic lesions.
    Bignold LP
    Cell Mol Life Sci; 2003 May; 60(5):883-91. PubMed ID: 12827278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenetic mechanisms of nuclear pleomorphism of tumour cells based on the mutator phenotype theory of carcinogenesis.
    Bignold LP
    Histol Histopathol; 2003 Apr; 18(2):657-64. PubMed ID: 12647815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mutator phenotype theory can explain the complex morphology and behaviour of cancers.
    Bignold LP
    Cell Mol Life Sci; 2002 Jun; 59(6):950-8. PubMed ID: 12169025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour morphology--interplay between chromosome aberrations and founder cell differentiation.
    Gisselsson D
    Histol Histopathol; 2002 Oct; 17(4):1207-12. PubMed ID: 12371148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of carcinogenesis with and without a mutator mutation.
    Beckman RA; Loeb LA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14140-5. PubMed ID: 16966602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaotic genomes make chaotic cells: the mutator phenotype theory of carcinogenesis applied to clinicopathological relationships of solid tumors.
    Bignold LP
    Cancer Invest; 2004; 22(3):338-43. PubMed ID: 15493353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of multiple mutations in cancer.
    Loeb KR; Loeb LA
    Carcinogenesis; 2000 Mar; 21(3):379-85. PubMed ID: 10688858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype.
    Chaves P; Cruz C; Lage P; Claro I; Cravo M; Leitão CN; Soares J
    J Pathol; 2000 Aug; 191(4):355-60. PubMed ID: 10918209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evolutionary model of carcinogenesis.
    Gatenby RA; Vincent TL
    Cancer Res; 2003 Oct; 63(19):6212-20. PubMed ID: 14559806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of carcinogenesis: is the mutator phenotype inevitable?
    Beckman RA
    Semin Cancer Biol; 2010 Oct; 20(5):340-52. PubMed ID: 20934514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply aggressive behaviour.
    Schaefer IM; Ströbel P; Cameron S; Beham A; Otto C; Schildhaus HU; Agaimy A
    Histopathology; 2014 Feb; 64(3):421-30. PubMed ID: 24266839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem-cell origin of metastasis and heterogeneity in solid tumours.
    Tu SM; Lin SH; Logothetis CJ
    Lancet Oncol; 2002 Aug; 3(8):508-13. PubMed ID: 12147437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesis.
    Koten JW; Neijt JP; Zonnenberg BA; Den Otter W
    Anticancer Res; 1993; 13(4):1179-82. PubMed ID: 8352541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.
    Van Keymeulen A; Lee MY; Ousset M; Brohée S; Rorive S; Giraddi RR; Wuidart A; Bouvencourt G; Dubois C; Salmon I; Sotiriou C; Phillips WA; Blanpain C
    Nature; 2015 Sep; 525(7567):119-23. PubMed ID: 26266985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutator mutations enhance tumorigenic efficiency across fitness landscapes.
    Beckman RA
    PLoS One; 2009 Jun; 4(6):e5860. PubMed ID: 19517009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway.
    Ortega P; Moran A; Fernandez-Marcelo T; De Juan C; Frias C; Lopez-Asenjo JA; Sanchez-Pernaute A; Torres A; Diaz-Rubio E; Iniesta P; Benito M
    Int J Oncol; 2010 May; 36(5):1209-15. PubMed ID: 20372795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of genetic instability and tumour formation: a review and hypothesis of a nongenotoxic mechanism.
    Bignold LP
    Cell Mol Life Sci; 2003 Jun; 60(6):1107-17. PubMed ID: 12861379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.